Haleon launches with purpose to deliver better everyday health with humanity
NewsPosted by: Dental Design 18th July 2022
With the demerger from GSK plc (GSK) now complete, maker of Sensodyne, Voltaren and Panadol becomes one of the world’s leading independent consumer health companies
Haleon (LSE/NYSE: HLN) has launched as an independent company 100% focused on consumer health, completing its demerger from GSK. The newly listed business is driven by its purpose to deliver better everyday health with humanity.
Trading commenced on Monday [18 July 2022] on the London Stock Exchange (LSE), with Brian McNamara, CEO of Haleon, leading the opening ceremony to signal the start of trading. Trading on the New York Stock Exchange (NYSE) is set to follow, and a similar market-opening event will take place on [Wednesday 20 July 2022].
Haleon has a world-class portfolio of brands including Panadol, Voltaren and Otrivin and will seek to continue to develop category leading brands that address real consumer health needs, while focusing on future innovation across its entire portfolio.
With an increased consumer focus on health and wellness, an ageing global population, an emerging middle class in high-growth economies, growing self-care in the face of increased pressure on public healthcare systems and sizeable unmet consumer needs, Haleon has launched at a time when the consumer healthcare market is set for expansion.
Despite huge improvements in medicine, data and technology, everyday health remains elusive for too many people. Haleon aims to change this through a two-pronged approach. First, by working to remove barriers to better everyday health, and second, by aiming to empower 50 million people a year by 2025 to be more included in opportunities for better everyday health.
The company’s competitive advantage lies in its ability to blend deep human understanding and trusted science in the products it creates. Haleon is further distinguished by leading consumer healthcare-focused scientific capabilities, a well-developed organisational understanding of human health behaviours, strong capabilities in brand building, innovation and digital commerce and a powerful route-to-market.
Brian McNamara, Chief Executive Officer, Haleon, said: “This is a significant milestone for Haleon. Guided by our clear purpose and with a world class portfolio of brands that people know and trust, we stand ready to help address consumer needs and make better everyday health more achievable, inclusive and sustainable.”
“Consumer health has never been more important than it is today, and I am delighted that Haleon, as an independent company, is ready to pursue our ambitions.”
“Today follows a huge amount of effort, planning and collaboration by our dedicated colleagues all around the world.”
The brands within the Haleon portfolio have been providing treatment and improving the quality of life for millions of consumers across the globe for decades. They have also been trusted, recognised, and recommended by healthcare professionals across multiple markets.
Tess Player, VP Global Head of Expert/Health Professionals, commented: “Partnering with health professionals is a top priority for Haleon. Our focus is to better help health professionals achieve positive health outcomes for their patients, which is why we are committed to building deeper relationships with them. We are actively listening and developing solutions, so we can tackle the challenges standing in the way of better everyday health with humanity, together.
“Simply put, we have a restless desire to do more. That’s why we’re focused on creating initiatives that raise the bar in the level of support for health professionals, patients, and everyday health.”
In preparation for launch, Haleon has been collaborating with health professionals to better understand the barriers they are facing including: a lack of education in patient communication, behaviour change and emerging technologies, as well as a lack of time and recognition from peers, policymakers, and even patients at times.
These insights will feed into some significant new programmes and developments aimed at the health professional community. This includes launching the new Haleon HealthPartner portal.
Haleon HealthPartner is specifically designed with health professionals in mind and provides access to Haleon’s health-focused scientific capabilities and deep understanding of human health behaviours. Here you will find professional education, practical tools and the latest on new services, as well as our awareness campaigns and community-building efforts in support of health professionals.
“We are developing Haleon HealthPartner as a space for continuous learning, collaboration and recognition. A platform through which Haleon and health professionals can engage and collaborate alongside a hub of tools and resources to support them in their daily roles that have been developed and tested by their peers.” Player adds.
Haleon (pronounced “Hay-Lee-On”) was unveiled as the name of the business in February 2022 and is inspired by the merging of the words ‘Hale’, which is an old English word meaning ‘in good health’ and Leon, which is associated with the word ‘strength’.
The company’s signature “For Health. With Humanity” brings to life the essence and purpose of Haleon and was developed by its own colleagues. The signature will appear with our logo when space allows as it underscores the purpose of Haleon.
Health professionals can find out more about Haleon on LinkedIn: https://bit.ly/3uWYHXQ.
